PT  - JOURNAL ARTICLE
AU  - So, Derek
TI  - Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy
DP  - 2011  01
TA  - MD Conference Express
PG  - 8--9
VI  - 11
IP  - 14
4099  - http://mdc.sagepub.com/content/11/14/8.short
4100  - http://mdc.sagepub.com/content/11/14/8.full
AB  - The primary objective of the Reassessment of Antiplatelet Therapy using an Individualized Strategy Based on Genetic Evaluation [RAPID GENE; NCT01184300] study was to evaluate the feasibility and test characteristics of a nurse-operated POC genetic test to determine CYP2C19*2 carrier status.